4-Ethyl-6,7-dimethoxyquinazoline

ADVERTISEMENT

Identification

Molecular formula
C12H14N2O2
CAS Number
22394-66-7
IUPAC Name
4-ethyl-6,7-dimethoxy-quinazoline
Molecular Weight
218.26g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2180g/cm3
Synonyms
QUAZODINE
Interesting facts

Interesting Facts about 4-ethyl-6,7-dimethoxy-quinazoline

4-ethyl-6,7-dimethoxy-quinazoline is a fascinating compound that belongs to the quinazoline family, which is well-known for its diverse biological activities. Here are some intriguing aspects of this compound:

  • Pharmacological Significance: Compounds in the quinazoline group often exhibit a wide range of biological properties, including antitumor, antihypertensive, and antimicrobial activities. 4-ethyl-6,7-dimethoxy-quinazoline could potentially be investigated for its pharmacological applications in drug development.
  • Structural Characteristics: The presence of ethyl and dimethoxy groups in its structure makes this compound unique. These substitutions can significantly influence its chemical reactivity and interaction with biological targets.
  • Synthesis Potential: The synthesis of quinazoline derivatives is an active area of research. Methods to create compounds like 4-ethyl-6,7-dimethoxy-quinazoline could involve simple reactions that yield a variety of functionalized derivatives, making it a valuable starting material for synthetic chemists.
  • Research Applications: Due to its unique structural motifs, this compound may serve as a probe in various research applications, including medicinal chemistry, agrochemicals, and materials science.
  • Customizable Framework: The quinazoline structure allows for modifications, meaning that chemists can tailor the compound's properties for specific research needs or therapeutic targets.

In summary, 4-ethyl-6,7-dimethoxy-quinazoline is a highly intriguing compound with promising implications in science and medicine. Its structural attributes and potential applications highlight the importance of exploring such compounds in the quest for novel therapeutic agents.

ADVERTISEMENT